[go: up one dir, main page]

MX2012001204A - Composiciones de polimero de acido hialuronico modificado y metodos relacionados. - Google Patents

Composiciones de polimero de acido hialuronico modificado y metodos relacionados.

Info

Publication number
MX2012001204A
MX2012001204A MX2012001204A MX2012001204A MX2012001204A MX 2012001204 A MX2012001204 A MX 2012001204A MX 2012001204 A MX2012001204 A MX 2012001204A MX 2012001204 A MX2012001204 A MX 2012001204A MX 2012001204 A MX2012001204 A MX 2012001204A
Authority
MX
Mexico
Prior art keywords
hyaluronic acid
modified hyaluronic
compositions
acid polymer
polymer compositions
Prior art date
Application number
MX2012001204A
Other languages
English (en)
Inventor
George Y Daniloff
David M Gravett
Pingren He
Original Assignee
Carbylan Biosurgery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42932126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012001204(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Carbylan Biosurgery Inc filed Critical Carbylan Biosurgery Inc
Publication of MX2012001204A publication Critical patent/MX2012001204A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente solicitud proporciona composiciones que comprenden ácido hialurónico que tienen bajos niveles de modificación de grupos funcionales, mezclas formadas por la reacción controlada de este ácido hialurónico ligeramente modificado con reticuladores difuncionales o multifuncionales adecuados, y composiciones de precursores de hidrogel y los hidrogeles resultantes. Las composiciones se reticulan ligeramente y poseen pocas propiedades pro-inflamatorias cuando se inyectan in vivo, y se pueden usar como, por ejemplo, dispositivos médicos, selladores y adhesivos biomédicos, y para la administración localizada de agentes bioactivos, entro otros usos.
MX2012001204A 2009-07-30 2010-07-23 Composiciones de polimero de acido hialuronico modificado y metodos relacionados. MX2012001204A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23007409P 2009-07-30 2009-07-30
US31195310P 2010-03-09 2010-03-09
PCT/US2010/043108 WO2011014432A1 (en) 2009-07-30 2010-07-23 Modified hyaluronic acid polymer compositions and related methods

Publications (1)

Publication Number Publication Date
MX2012001204A true MX2012001204A (es) 2012-08-03

Family

ID=42932126

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001204A MX2012001204A (es) 2009-07-30 2010-07-23 Composiciones de polimero de acido hialuronico modificado y metodos relacionados.

Country Status (15)

Country Link
US (5) US7829118B1 (es)
EP (1) EP2459239A1 (es)
JP (1) JP5683587B2 (es)
KR (1) KR101551681B1 (es)
CN (1) CN102573941B (es)
AU (1) AU2010276574B2 (es)
BR (1) BR112012002117A2 (es)
CA (1) CA2769470A1 (es)
CL (1) CL2012000243A1 (es)
IL (1) IL217750B (es)
MX (1) MX2012001204A (es)
RU (1) RU2539395C2 (es)
SG (1) SG178146A1 (es)
WO (1) WO2011014432A1 (es)
ZA (1) ZA201200727B (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5683587B2 (ja) 2009-07-30 2015-03-11 カービラン バイオサージェリー， インコーポレイテッド 修飾ヒアルロン酸ポリマー組成物および関連する方法
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ2009835A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
WO2012008722A2 (ko) * 2010-07-12 2012-01-19 신풍제약 주식회사 조직 증강용 충전 조성물
FR2968306B1 (fr) * 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
US20120142628A1 (en) * 2010-12-07 2012-06-07 Allergan, Inc. Methods for treating crepitus
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
JP5998201B2 (ja) * 2011-04-20 2016-09-28 カービラン セラピューティクス， インコーポレイテッド Ｉｎ−ｓｉｔｕゲル形成組成物
CZ304072B6 (cs) * 2011-04-26 2013-09-25 Contipro Biotech S.R.O. Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití
US9186377B2 (en) * 2011-06-03 2015-11-17 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
WO2012171335A1 (en) * 2011-06-16 2012-12-20 The Hong Kong University Of Science And Technology Multi-vinylsulfone containing molecule
TWI561535B (en) 2011-10-06 2016-12-11 Bvw Holding Ag Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption
US20130108550A1 (en) 2011-10-26 2013-05-02 Abbott Cardiovasculr Systems, Inc. Bioabsorbable Co-Filler for Cerebrovascular Aneurysms
US20150087725A1 (en) * 2011-12-02 2015-03-26 Hong Kong Universit of Science and Technology Injectable Gelling Material
CZ303879B6 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
AU2014205213B2 (en) * 2013-01-11 2017-09-21 Carbylan Therapeutics, Inc. Stabilized compositions comprising hyaluronic acid
US9833460B2 (en) * 2013-01-23 2017-12-05 Semnur Pharmaceuticals, Inc. Pharmaceutical formulation
ES2692150T3 (es) * 2013-02-04 2018-11-30 W.L. Gore & Associates, Inc. Revestimiento para sustrato
JP6781220B2 (ja) * 2013-02-04 2020-11-04 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティドＷ．Ｌ． Ｇｏｒｅ ＆ Ａｓｓｏｃｉａｔｅｓ， Ｉｎｃｏｒｐｏｒａｔｅｄ 基板用コーティング
US9511119B2 (en) * 2013-03-15 2016-12-06 NuTech Spine, Inc. Preparations containing hepatocyte growth factor and hyaluronic acid and methods of making and using same
CN105209075B (zh) * 2013-04-18 2019-12-13 香港科技大学 生物相容性原位水凝胶
BR112015031589A2 (pt) * 2013-06-28 2017-07-25 Galderma Sa método para a fabricação de um produto moldado de ácido hialurônico reticulado
CN105658674B (zh) * 2013-10-08 2019-04-09 丘比株式会社 含有羧甲基的修饰透明质酸和/或其盐和/或其制造方法
WO2015053281A1 (ja) * 2013-10-08 2015-04-16 キユーピー株式会社 カルボキシメチル基含有修飾ヒアルロン酸および／またはその塩の架橋物およびその製造方法
WO2015053282A1 (ja) * 2013-10-08 2015-04-16 キユーピー株式会社 カルボキシメチル基含有修飾ヒアルロン酸および／またはその塩の架橋物およびその製造方法
WO2015134906A1 (en) * 2014-03-07 2015-09-11 Endologix, Inc. Forming hydrogels and materials therefor
US9895394B2 (en) * 2014-03-10 2018-02-20 Kai-shun Christopher LEUNG Induction of chronic elevation of intraocular pressure with vinysulfonated hyaluronic acid (HA-VS) and thiolated hyaluronic acid (HA-SH)hydrogel
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
KR102882700B1 (ko) 2014-08-15 2025-11-07 더 존스 홉킨스 유니버시티 조직 복원용 복합 재료
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
EP3320028A1 (en) * 2015-09-01 2018-05-16 Merz Pharma GmbH & Co. KGaA Method of making a cross-linked polymer gel and device for performing the method
EP3347061B1 (en) * 2015-09-09 2021-05-19 ETH Zürich Injectable macroporous hydrogels
EP3359200B1 (en) * 2015-10-05 2023-08-02 Board of Regents, The University of Texas System Micro-and nano-device for cartilage injury detection and treatment
CN105606602A (zh) * 2015-12-22 2016-05-25 上海景峰制药有限公司 一种测定交联透明质酸钠凝胶中二巯基聚乙二醇残留的方法
TWI727014B (zh) * 2016-03-24 2021-05-11 德商梅茲製藥有限兩合公司 修飾透明質酸與其製造方法及其用途
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
KR20180027126A (ko) 2016-09-06 2018-03-14 (주)한국비엠아이 가교화 히알루론산 유도체 매트릭스가 포함된 지혈 조성물
EP3525584B1 (en) * 2016-10-14 2023-05-03 Wake Forest University Health Sciences Multi-organ "body on a chip" apparatus utilizing a common media
US11116715B2 (en) 2017-02-28 2021-09-14 Cg Bio Co., Ltd. Composition for dermal injection
WO2018159983A1 (ko) 2017-02-28 2018-09-07 (주)시지바이오 피부 주입용 조성물
AU2018228301B2 (en) * 2017-02-28 2020-12-17 Cg Bio Co., Ltd. Composition For Dermal Injection
MX2019010438A (es) * 2017-03-01 2019-11-18 Church & Dwight Co Inc Composicion gomosa con estabilidad mejorada.
PE20191758A1 (es) 2017-03-22 2019-12-12 Genentech Inc Composiciones de anticuerpo optimizadas para el tratamiento de trastornos oculares
US11419941B2 (en) * 2017-05-30 2022-08-23 Brenda K. Mann Vaginal hydrogel
US11440976B2 (en) 2017-09-01 2022-09-13 Pmidg, Llc Functionalized and crosslinked polymers
US12029753B2 (en) 2017-09-19 2024-07-09 The Hong Kong University Of Science And Technology Biocompatible material and methods for making and using thereof
US20190240335A1 (en) * 2018-02-07 2019-08-08 Promedon S.A. Biocompatible Hydrogel Compositions
US10959945B2 (en) 2018-03-21 2021-03-30 Marina Lee Gerton Vaginal hydrogel for delivery of therapeutics
CN112423799A (zh) 2018-05-09 2021-02-26 约翰·霍普金斯大学 用于增强的软组织替代和再生的纳米纤维-水凝胶复合物
CA3099732A1 (en) 2018-05-09 2019-11-14 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
CN112702992A (zh) * 2018-07-20 2021-04-23 香港科技大学 用于靶试剂的受控释放的组合物和方法
CN109045354B (zh) * 2018-07-26 2020-12-08 华中科技大学 一种用于骨-软骨综合修复的原位成型可注射水凝胶
US20210353759A1 (en) * 2018-09-20 2021-11-18 The Hong Kong University Of Science And Technology Eyedrop compositions
CN109223708B (zh) * 2018-10-24 2021-07-20 上海景峰制药有限公司 一种交联玻璃酸钠的抗肿瘤药物组合物及其制备方法和应用
EP3956367A1 (en) * 2019-04-19 2022-02-23 Jointherapeutics S.r.l. Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
KR102176486B1 (ko) * 2019-06-14 2020-11-10 동국대학교 산학협력단 히알루론산 기반의 안과용 약물전달체의 제조방법
CN111187429B (zh) * 2019-06-18 2020-08-14 吾奇生物医疗科技(镇江)有限公司 双交联胶原水凝胶材料、其制备方法与应用
WO2020264392A1 (en) * 2019-06-26 2020-12-30 Lacerta Technologies Inc. Cross-linked hyaluronic acid hydrogels comprising proteins
CN110204746B (zh) * 2019-06-28 2022-03-08 浙江科技学院 一种交联透明质酸钠凝胶的制备方法
CN115135303A (zh) * 2020-01-16 2022-09-30 香港科技大学 用于控释目标药剂的组合物和方法
EP4135772A4 (en) * 2020-04-17 2024-04-24 Brendan Patrick Purcell Controlled release hyaluronic acid compositions
US20230173074A1 (en) * 2020-04-23 2023-06-08 Pleryon Therapeutics (Shenzhen) Limited Biocompatible material and methods for making and using the same
WO2022120097A1 (en) * 2020-12-03 2022-06-09 Pmidg, Llc Functionalized and crosslinked polymers
CN114276563B (zh) * 2020-12-14 2023-02-24 南京工业大学 医用水凝胶的制备方法、水凝胶及敷料
EP4284338A4 (en) * 2021-02-01 2024-12-04 The Regents Of The University Of Colorado, A Body Corporate COMPOSITIONS AND METHODS OF MAKING AND USING HYBRID NETWORK HYDROGELS
KR102888000B1 (ko) * 2021-10-25 2025-11-24 바이오플러스 주식회사 가교 히알루론산을 포함하는 가슴 보형물 및 이의 제조방법
DE102021212812A1 (de) * 2021-11-15 2023-05-17 Bauerfeind Ag Entzündungshemmendes viskosupplementierendes Mittel enthaltend Hyaluronsäure
EP4115741B1 (en) * 2021-11-16 2024-09-25 Pompadour Ibérica S.A. A beverage composition with controlled effervescence for infusion in a cold liquid
CN115364044B (zh) * 2022-06-17 2024-07-09 浙江大学医学院附属第一医院 一种药物组合物及其制备方法和用途
WO2024030437A1 (en) * 2022-08-01 2024-02-08 Pmidg, Llc Functionalized and crosslinked polymer methods and compositions
EP4665295A1 (en) * 2023-02-15 2025-12-24 Lifesprout, Inc. Modified crosslinked polymers
CN120958068A (zh) * 2023-02-15 2025-11-14 生命萌芽公司 胶原蛋白-水凝胶复合材料
FI20245016A1 (en) * 2024-01-11 2025-07-12 Fysioline Oy INJECTABLE COMPOSITION FOR CONTROLLED MEDICINE ADMINISTRATION

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
DK130991D0 (da) 1991-07-04 1991-07-04 Immunodex K S Polymere konjugater
DK2111876T3 (da) 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Tværbundne polymerpræparater og fremgangsmåder til anvendelse deraf
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
ES2217496T3 (es) * 1998-02-27 2004-11-01 Stichting Hippomedics Proceso para producir acido hialuronico reticulado.
US6056970A (en) 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6521223B1 (en) * 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
ATE392907T1 (de) 2000-07-28 2008-05-15 Anika Therapeutics Inc Bioabsorbierbare kompositmaterialien aus derivatisierter hyaluronsäure
ATE312076T1 (de) 2001-02-22 2005-12-15 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
CN101078718A (zh) 2002-05-08 2007-11-28 松下电器产业株式会社 含生物分子珠粒的管和使用它的分析装置
US7034127B2 (en) * 2002-07-02 2006-04-25 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
US6802377B2 (en) 2002-08-28 2004-10-12 Mark S. Foltz Hammer mounting apparatus
JP4636883B2 (ja) 2002-11-21 2011-02-23 中外製薬株式会社 薬物徐放担体
US20050056608A1 (en) 2003-09-15 2005-03-17 Nesin Milton Scott Bottle insert for storing and dispensing baby formula
US20050282747A1 (en) * 2003-10-01 2005-12-22 The Research Foundation Of State University Of New York At Stony Brook Methods and compositions for wound healing
KR101233564B1 (ko) 2003-11-14 2013-02-15 추가이 세이야쿠 가부시키가이샤 가교 다당 미립자 및 그 제조 방법
ZA200604869B (en) 2003-12-04 2007-11-28 Univ Utah Res Found Modified macromolecules and methods of making and using thereof
CA2548929A1 (en) 2003-12-12 2005-06-23 Chugai Seiyaku Kabushiki Kaisha Cell death inducing agent
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
BRPI0418309B8 (pt) * 2003-12-30 2021-05-25 Genzyme Corp "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis".
TW200612991A (en) 2004-09-07 2006-05-01 Chugai Pharmaceutical Co Ltd Process for producing water-soluble hyaluronic acid modification
WO2006051950A1 (ja) * 2004-11-15 2006-05-18 Shiseido Co., Ltd. 架橋ヒアルロン酸ゲルの製造方法
CN101107270B (zh) 2004-11-24 2011-11-23 诺维信生物制药丹麦公司 用二乙烯基砜交联透明质酸的方法
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
EP1994062B1 (en) 2006-03-02 2009-07-15 Novozymes Biopolymer A/S Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
DE602006014667D1 (de) 2006-06-23 2010-07-15 Nippon Office Automation Co Lt Protokoll- und Sitzunganalysator
WO2008008857A2 (en) 2006-07-11 2008-01-17 University Of Utah Research Foundation Thiolated macromolecules and methods of making and using thereof
TWI436793B (zh) 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
CN101200504B (zh) 2006-12-11 2010-05-12 上海百瑞吉生物医药有限公司 高分子巯基化改性衍生物及其交联材料
US20110077737A1 (en) 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
JP5683587B2 (ja) * 2009-07-30 2015-03-11 カービラン バイオサージェリー， インコーポレイテッド 修飾ヒアルロン酸ポリマー組成物および関連する方法
US8273725B2 (en) 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation

Also Published As

Publication number Publication date
US20140328926A1 (en) 2014-11-06
KR20120052371A (ko) 2012-05-23
AU2010276574A1 (en) 2012-02-23
IL217750B (en) 2018-01-31
US9192678B2 (en) 2015-11-24
IL217750A0 (en) 2012-03-29
ZA201200727B (en) 2013-05-29
JP2013501091A (ja) 2013-01-10
CA2769470A1 (en) 2011-02-03
US20160193342A1 (en) 2016-07-07
US9980977B2 (en) 2018-05-29
WO2011014432A1 (en) 2011-02-03
RU2012107283A (ru) 2013-09-10
US20120128741A1 (en) 2012-05-24
BR112012002117A2 (pt) 2019-09-24
CN102573941B (zh) 2014-10-29
JP5683587B2 (ja) 2015-03-11
AU2010276574B2 (en) 2015-08-20
KR101551681B1 (ko) 2015-09-09
EP2459239A1 (en) 2012-06-06
US20170224708A1 (en) 2017-08-10
US8790702B2 (en) 2014-07-29
US9446136B2 (en) 2016-09-20
CN102573941A (zh) 2012-07-11
SG178146A1 (en) 2012-03-29
US7829118B1 (en) 2010-11-09
CL2012000243A1 (es) 2012-12-21
RU2539395C2 (ru) 2015-01-20

Similar Documents

Publication Publication Date Title
MX2012001204A (es) Composiciones de polimero de acido hialuronico modificado y metodos relacionados.
EA200971116A1 (ru) Способ желатинизации фиброина шелка с применением обработки ультразвуком
WO2009155594A3 (en) Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
EA201300898A1 (ru) Композиция для окислительного фотоактивируемого омоложения кожи, содержащая гиалуроновую кислоту, глюкозамин или аллантоин
JO2932B1 (en) Lyspro insulin compounds linked to PEG
WO2011109732A3 (en) Reverse thermal gels and uses therefor
WO2011084513A3 (en) Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
WO2009120365A3 (en) Methods and compositions for the delivery of agents
WO2012008722A3 (ko) 조직 증강용 충전 조성물
MX2009006033A (es) Composiciones y articulos que contienen una matriz de polimero reticulado y un liquido activo inmovilizado, asi como metodos para fabricarlos.
NZ708105A (en) A composition for treating diabetes or diabesity comprising oxyntomodulin analog
WO2010068862A3 (en) Zwitterionic polymers with therapeutic moieties
WO2008147817A3 (en) Coated hyaluronic acid particles
WO2009005790A3 (en) Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof
WO2010036729A3 (en) Wellbore treatment compositions
WO2009155589A3 (en) Stable and sterile tissue adhesive composition with a controlled high viscosity
MX2012002364A (es) Geles viscoelasticos como rellenos novedosos.
WO2008054772A3 (en) Implantable elastomeric caprolactone depot compositions and uses thereof
WO2011028031A3 (en) In situ-forming hydrogel for tissue adhesives and biomedical use thereof
WO2008115694A3 (en) Polymerization of multifunctional azides, and polymers therefrom
WO2008021548A3 (en) Epoxy-containing poly(ester amides) and methods of use
WO2011148116A3 (fr) Acide hyaluronique modifie, procede de fabrication et utilisations
WO2009081408A3 (en) Pulverized fibrin clots and pharmaceutical compositions containing them
MX2015015079A (es) Geles de nano-red inyectables para tratamiento de diabetes.
AU2007211617A8 (en) Hydrogel

Legal Events

Date Code Title Description
FG Grant or registration